Bryan P. Toole

Medical University of South Carolina, Charleston, SC, United States 
Cell Biology, Oncology
"Bryan Toole"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dai L, Qiao J, Nguyen D, et al. (2016) Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus. Oncotarget
Grass GD, Toole BP. (2016) How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity. Bioscience Reports. 36: e00283
Dai L, Trillo-Tinoco J, Chen Y, et al. (2015) CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells. Oncotarget
Grass GD, Dai L, Qin Z, et al. (2014) CD147: regulator of hyaluronan signaling in invasiveness and chemoresistance. Advances in Cancer Research. 123: 351-73
Grass GD, Tolliver LB, Bratoeva M, et al. (2013) CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness. The Journal of Biological Chemistry. 288: 26089-104
Dai L, Bai L, Lu Y, et al. (2013) Emmprin and KSHV: new partners in viral cancer pathogenesis. Cancer Letters. 337: 161-6
Dai L, Guinea MC, Slomiany MG, et al. (2013) CD147-dependent heterogeneity in malignant and chemoresistant properties of cancer cells. The American Journal of Pathology. 182: 577-85
Qin Z, Dai L, Defee M, et al. (2013) Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection. Journal of Virology. 87: 621-35
Grass GD, Bratoeva M, Toole BP. (2012) Regulation of invadopodia formation and activity by CD147. Journal of Cell Science. 125: 777-88
Dai L, Qin Z, Defee M, et al. (2012) Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts. Cancer Letters. 318: 214-20
See more...